对利益冲突的追查是否过头了？答案是肯定的。
Has the hunt for conflicts of interest gone too far? Yes.
作者信息
Stossel Thomas P
机构信息
Department of Medicine, Harvard Medical School, Translational Medicine and Hematology Divisions, Brigham and Women's Hospital, 1 Blackfan Circle, Karp 6, Boston, MA 02115 USA.
出版信息
BMJ. 2008 Mar 1;336(7642):476. doi: 10.1136/bmj.39493.489213.AD.
Abstract
argues that restrictions on doctors’ and academics’ interaction with commercial companies are damaging research, but believes it is a price worth paying to maintain public trust
摘要
认为对医生和学者与商业公司互动的限制正在损害研究，但认为这是为维持公众信任而值得付出的代价
相似文献
1
Has the hunt for conflicts of interest gone too far? Yes.对利益冲突的追查是否过头了？答案是肯定的。
BMJ. 2008 Mar 1;336(7642):476. doi: 10.1136/bmj.39493.489213.AD.
2
Has the hunt for conflicts of interest gone too far? No.对利益冲突的追查是否过头了？答案是否定的。
BMJ. 2008 Mar 1;336(7642):477. doi: 10.1136/bmj.39491.391215.94.
3
When conflict-of-interest is a factor in scientific misconduct.当利益冲突成为科研不端行为的一个因素时。
Med Law. 2007 Sep;26(3):447-63.
4
[Actuality of conflicts of interests in medicine. From financial interests to the run for scientific publication].[医学利益冲突的现状。从经济利益到争夺科研发表]
Bull Cancer. 2021 Jul-Aug;108(7-8):677-685. doi: 10.1016/j.bulcan.2021.04.013. Epub 2021 Jun 24.
5
Conflicting interests in biomedical research and medical practice.生物医学研究与医疗实践中的利益冲突。
Vojnosanit Pregl. 2016 Jun;73(6):603-6. doi: 10.2298/vsp1606603i.
6
Tackling conflict of interest and misconduct in biomedical research.应对生物医学研究中的利益冲突和不当行为。
Indian Pediatr. 2012 Jul;49(7):527-31. doi: 10.1007/s13312-012-0114-5.
7
[Conflict of interest and misconduct in science].
Nihon Yakurigaku Zasshi. 2007 Oct;130(4):275-80. doi: 10.1254/fpj.130.275.
8
Caveat lector.读者注意。
Md Med. 2007 Winter;8(1):15-6.
9
Drugs, devices and doctors.药物、器械与医生。
N Y Times Web. 2005 Dec 16:A41.
10
Ethics, industry, and outcomes.伦理、行业与结果。
Semin Cardiothorac Vasc Anesth. 2008 Mar;12(1):7-11. doi: 10.1177/1089253207311142.
引用本文的文献
1
Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation.规范医生与制药公司之间的关系：对以色列立法影响的定性和描述性分析
Isr J Health Policy Res. 2017 Sep 26;6(1):45. doi: 10.1186/s13584-017-0170-3.
2
Association Between Financial Conflicts of Interests and Supportive Opinions for Erectile Dysfunction Treatment.经济利益冲突与勃起功能障碍治疗支持性观点之间的关联
J Bioeth Inq. 2016 Sep;13(3):439-48. doi: 10.1007/s11673-016-9732-2. Epub 2016 Jul 14.
3
Antipsychotic prescribing: do conflict of interest policies make a difference?抗精神病药物处方：利益冲突政策有作用吗？
Med Care. 2015 Apr;53(4):338-45. doi: 10.1097/MLR.0000000000000329.
4
The Sunshine Act: commercial conflicts of interest and the limits of transparency.《阳光法案》：商业利益冲突与透明度的局限
Open Med. 2014 Jan 14;8(1):e10-3. eCollection 2014.
5
Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.医学生接触和对制药行业的态度：系统评价。
PLoS Med. 2011 May;8(5):e1001037. doi: 10.1371/journal.pmed.1001037. Epub 2011 May 24.
6
Conflict of interest in science communication: more than a financial issue. Report from Esteve Foundation Discussion Group, April 2009.科学传播中的利益冲突：不止是财务问题。埃斯特维基金会讨论小组报告，2009年4月
Croat Med J. 2010 Feb;51(1):7-15. doi: 10.3325/cmj.2010.51.7.
7
[Conflict of interest declarations in scientific publications].[科学出版物中的利益冲突声明]
Nervenarzt. 2008 Sep;79(9):1001-5. doi: 10.1007/s00115-008-2543-x.
本文引用的文献
1
A biopsy of financial conflicts of interest in medicine.
Surgery. 2008 Feb;143(2):193-8. doi: 10.1016/j.surg.2007.11.013.
2
Doctors and drug companies--scrutinizing influential relationships.医生与制药公司——审视有影响力的关系。
N Engl J Med. 2007 Nov 1;357(18):1796-7. doi: 10.1056/NEJMp078141.
3
California campuses resist industry restrictions.加州各校园抵制行业限制。
Nature. 2007 Jul 26;448(7152):394-5. doi: 10.1038/448394b.
4
Reproducible research: moving toward research the public can really trust.可重复性研究：迈向公众真正能信任的研究。
Ann Intern Med. 2007 Mar 20;146(6):450-3. doi: 10.7326/0003-4819-146-6-200703200-00154. Epub 2007 Mar 5.
5
Regulation of financial conflicts of interest in medical practice and medical research: a damaging solution in search of a problem.医学实践和医学研究中经济利益冲突的监管：一个在寻找问题的有害解决方案。
Perspect Biol Med. 2007 Winter;50(1):54-71. doi: 10.1353/pbm.2007.0011.
6
What have we learnt from Vioxx?我们从万络中学到了什么？
BMJ. 2007 Jan 20;334(7585):120-3. doi: 10.1136/bmj.39024.487720.68.
7
The value of medical spending in the United States, 1960-2000.1960年至2000年美国医疗支出的价值。
N Engl J Med. 2006 Aug 31;355(9):920-7. doi: 10.1056/NEJMsa054744.
8
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.引发利益冲突的医疗行业行为：针对学术医疗中心的一项政策提案
JAMA. 2006 Jan 25;295(4):429-33. doi: 10.1001/jama.295.4.429.
9
Regulating academic-industrial research relationships--solving problems or stifling progress?规范学术-产业研究关系——是解决问题还是阻碍进步？
N Engl J Med. 2005 Sep 8;353(10):1060-5. doi: 10.1056/NEJMsb051758.
10
Physicians and the pharmaceutical industry: is a gift ever just a gift?医生与制药行业：礼物仅仅只是礼物吗？
JAMA. 2000 Jan 19;283(3):373-80. doi: 10.1001/jama.283.3.373.
Zotero 插件